PRE 14A

PROXY STATEMENT

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filed: April 25, 2025
Period of Report: April 25, 2025
Accession Number: 0001213900-25-035562

View Document ↗ View on SEC.gov ↗